Orexigen Therapeutics, Inc. OREXQ
We take great care to ensure that the data presented and summarized in this overview for Orexigen Therapeutics, Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Latest Institutional Activity in OREXQ
Top Purchases
Top Sells
About OREXQ
Insider Transactions at OREXQ
Insider Transaction List
View allDate | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Oct 31
2018
|
Baupost Group LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
896,339
-100.0%
|
$0
$0.01 P/Share
|
Oct 29
2018
|
Baupost Group LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
650,000
-42.03%
|
$0
$0.01 P/Share
|
Oct 25
2018
|
Baupost Group LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
652,500
-29.67%
|
$0
$0.01 P/Share
|
Oct 24
2018
|
Baupost Group LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
28,000
-1.26%
|
$0
$0.01 P/Share
|
Last 12 Months Summary
Buy / Acquisition
0
Shares
From
0
Insiders
Sell / Disposition
0
Shares
From
0
Insiders